{
    "clinical_study": {
        "@rank": "63878", 
        "acronym": "ISIS", 
        "brief_summary": {
            "textblock": "The purpose of this study is to study the impact of the immediate implant breast\n      reconstruction for patients with mastectomy and postoperative chest wall radiotherapy"
        }, 
        "brief_title": "Immediate Implant Breast Reconstruction", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "non applicable"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed breast carcinoma\n\n          -  Patients planned for mastectomy with immediate single stage breast reconstruction\n             using an acellular dermal matrix (Strattice\u2122, LifeCell Corporation)\n\n          -  Patients planned to receive postoperative chest wall irradiation\n\n          -  Age \u2265 18 years old\n\n          -  WHO performance status 0-1\n\n          -  Affiliation to a social security system\n\n          -  Informed consent signed prior any study specific procedures\n\n        Exclusion Criteria:\n\n          -  Inflammatory breast cancer\n\n          -  Tumors with extensive involvement of the skin\n\n          -  Use of tissue expander\n\n          -  Indication of postoperative chemotherapy\n\n          -  Patients planned for bilateral mastectomy\n\n          -  History of previously treated ipsilateral breast carcinoma\n\n          -  Usual  contraindications for ADM\n\n          -  Medical debility precluding surgical treatment\n\n          -  Psychological, social, geographical disorders or any other condition that would\n             preclude study compliance (treatment modalities and study follow-up).\n\n          -  Pregnancy or breast feeding\n\n          -  Inability to attend or comply with interventions or follow-up scheduling, disability\n             or difficulty preventing a proper understanding of trial instructions\n\n          -  Legal inability or restricted legal ability"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02055937", 
            "org_study_id": "VA2012/37", 
            "secondary_id": "2012-A01369-34"
        }, 
        "intervention": {
            "description": "Eligible patients will undergo radical mastectomy with axillary lymph nodes sampling followed by immediate and single-stage breast reconstruction using the acellular dermal matrix Strattice\u2122", 
            "intervention_name": "immediate implant breast reconstruction", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "mastectomy, reconstruction", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "contact": {
                "email": "jean-pierre.bleuse@icm.unicancer.fr", 
                "last_name": "jean pierre bleuse", 
                "phone": "0033467613102"
            }, 
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34000"
                }, 
                "name": "Institut r\u00e9gional du Cancer - Montpellier - Val d'Aurelle"
            }, 
            "investigator": {
                "last_name": "philippe rouanet", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Immediate Implant Breast Reconstruction for Patients With Mastectomy Ans Post op\u00e9rative Chest Wall Radiotherapy", 
        "other_outcome": [
            {
                "description": "Cosmetic results: assessed by both the surgeon and patient (patient satisfaction will be evaluated using a self-questionnaire). Photographs of the breast will be taken at different times (Pre / per / postoperative) and the picture analysis will be reviewed by an independent committee.", 
                "measure": "Cosmetic results", 
                "safety_issue": "No", 
                "time_frame": "up to 36 months after surgery"
            }, 
            {
                "description": "Functional results: patient satisfaction will be evaluated using a self-questionnaire", 
                "measure": "Functional results", 
                "safety_issue": "No", 
                "time_frame": "up to 36 months after surgery"
            }, 
            {
                "description": "The rate of patients requiring breast implant removal", 
                "measure": "The rate of patients requiring breast implant removal", 
                "safety_issue": "No", 
                "time_frame": "up to 36 months after surgery"
            }, 
            {
                "description": "Study of the indesirable effect of the radiotherapy on the implant", 
                "measure": "Study of tolerance", 
                "safety_issue": "No", 
                "time_frame": "up to 36 months after surgery"
            }
        ], 
        "overall_contact": {
            "email": "jean-pierre.bleuse@icm.unicancer.fr", 
            "last_name": "jean pierre bleuse", 
            "phone": "0033467613102"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Success is defined as a complete therapeutic sequence (surgery + RT) without any significant complication at 6 months.\nSignificant complication is defined as:\nAny event delaying RT (delay surgery/RT > 3 months)\nAny event preventing patients from receiving radiotherapy within 6 months after surgery", 
            "measure": "Success is defined as a complete therapeutic sequence (surgery + RT) without any significant complication at 6 months.", 
            "safety_issue": "Yes", 
            "time_frame": "confirm the feasibility of the therapeutic sequence at 6 months"
        }, 
        "reference": {
            "PMID": "16432358", 
            "citation": "Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg. 2006 Feb;243(2):241-9."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02055937"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The rate of Baker grades 3/4 capsular contracture", 
            "measure": "The rate of Baker", 
            "safety_issue": "No", 
            "time_frame": "up to 36 months after surgery"
        }, 
        "source": "Centre Val d'Aurelle - Paul Lamarque", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Val d'Aurelle - Paul Lamarque", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}